I think is near on impossible to come up with a meaningful share price target...why? Because there are just too many factors and the TGA Provisional acceptance isn't the only thing in isolation that we are taking on, PLUS of course some influence from external world events will play a role.
If we were in a vacuum and you could somehow isolate all the other programs and events we are involved with, you'd have to think a target of some $6 - $7 or so wouldn't be implausible on successful TGA Provisional Go-Ahead. You have to be a little cautious though as there is a little evidence indicating some companies in the past didn't necessarily get a massive boost on the positive acceptance by TGA, it came later as their sales ramped. From there (after TGA Provisional acceptance) it will be up to sales, if it constantly ramps then our SP should too as the market gets a better sense of just what we have, how popular it is and exactly what it's benefit are to people at scale?
My spec. views only
- Forums
- ASX - By Stock
- PAR
- The Possible TGA Timetable - Traffic light style
The Possible TGA Timetable - Traffic light style, page-13
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.3¢ |
Change
0.008(3.33%) |
Mkt cap ! $81.36M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $125.9K | 542.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 59178 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 3650 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 59178 | 0.230 |
9 | 111700 | 0.225 |
7 | 54112 | 0.220 |
11 | 228961 | 0.215 |
15 | 571546 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 3650 | 2 |
0.240 | 135179 | 7 |
0.245 | 66601 | 4 |
0.250 | 99540 | 6 |
0.255 | 4904 | 1 |
Last trade - 13.21pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online